Discussion
When I think back to my diagnosis with immune thrombocytopenia (ITP), one of the things I remember most vividly is the color purple. Not…
The final results of a now-completed global clinical trial have confirmed that the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) prevents acute disease episodes in people with severe congenital thrombotic thrombocytopenic purpura (TTP). Further, this prophylactic med causes fewer treatment-related side effects than plasma-based therapy among people with the ultra-rare…
Latest news & perspectives
Discussion
Discussion
Nearly half of adults with immune thrombocytopenia (ITP) had cognitive impairment, particularly difficulties with memory, decision-making, and problem solving, a study found. However, the…
